CorMedix Inc CRMD
$7.53
▲ +0.53%
(+$0.04)
🔥 High Short Interest
📅 Earnings This Week
Open
$7.49
Prev Close
$7.49
Day Range
$7.30 – $7.55
52W Range
$6.13 – $14.96
Market Cap
$590.74M
P/E (TTM)
3.26
Beta
1.51
EPS (TTM)
$2.10
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-03-25 |
| Shares Out. | 78,450,000 |
| Website | cormedix.com/ ↗ |
| Phone | 13026365400 |
| Employees | 191 |
| Revenue | $127.4M |
| Gross Profit | $105.1M |
| Net Income | $38.6M |
| Free Cash Flow | $194.7M |
| Total Assets | $815.6M |
| Total Liabilities | $378.6M |
| Equity | $437.0M |
About CorMedix Inc
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
CorMedix Inc is a publicly traded company under the ticker symbol CRMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)